SecBot SecBot
8-K ·Filed Aug 10, 2026

PIII

P3 Health Partners Inc.
BULLISH
Impact 7/10
Horizonweeks Processed2mo ago SEC0001832511-26-000032
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The strong earnings beat and raised EBITDA guidance are positive, but the continued membership decline and the dilutive preferred stock issuance (creating senior claims on earnings) temper enthusiasm. Traders should watch for Q3 membership trends and the sustainability of medical margin improvements excluding one-time items.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+20d ⚠ clustered
PIII ▼ -31.93% at T+20d
LONG call ✗ call lost -31.93% · α vs SPY -30.87% · entry $12.37 → $8.42
Next anchor: T+60d in 7d
Latest observation: T+33 -78.55% FF3 residual α
Entry = T+0 close
Aug 10, 2026
via day close
T+1d
-5.50%
call -5.50% · α -5.75%
$11.69
settled 3mo ago
T+5d
-12.93%
call -12.93% · α -12.53%
$10.77
settled 2mo ago
T+20d
-31.93%
call -31.93% · α -30.87%
$8.42
settled 7w ago
T+60d
Pending
in 7d

Price Chart

Loading chart...

Executive Summary

P3 Health Partners delivered a strong Q2 2026 earnings beat, reporting GAAP net income of $15.7 million vs a net loss of $43.7 million a year ago, and total revenue of $386 million (+9% YoY), above consensus. The company raised its full-year 2026 Adjusted EBITDA guidance to a range of $80-$110 million, driven by structural improvements and favorable prior-year development. However, at-risk membership continued to decline 10% YoY due to intentional network rationalization, and the company issued a significant amount of preferred stock and warrants, adding debt-like obligations.

Key Financial Metrics

EPS
$0.32
est −$1.90 · +116.9%
Revenue
$386.4M
est $377.8M · +2.3% · +8.6% YoY
Rating
strong beat
Guidance
$1,500M-$1,600M
raised

Key Facts

  • Total revenue for Q2 2026 was $386 million, a 9% increase YoY.
  • GAAP net income of $15.7 million, compared to a net loss of $43.7 million in Q2 2025.
  • Adjusted EBITDA of $54.4 million (Q2 2025: -$17.1 million loss).
  • Full-year 2026 Adjusted EBITDA guidance raised to $80-$110 million (prior midpoint: $40M; see cross-filing context Q1 earnings).
  • At-risk membership of ~105,000, down 10% YoY, due to intentional network and payer rationalization.
  • Medical margin of $97.8 million, or $311 PMPM, included favorable prior-year development and payer settlements.
  • Issued Series A-D cumulative preferred stock (total gross ~$164M on balance sheet) and warrants for proceeds.
  • Total debt reduced significantly: current + long-term debt fell from ~$273M (Dec 2025) to ~$120M (June 2026), though cash also decreased.

Financial Impact

Net income swing of +$59.3M YoY, Adjusted EBITDA swing from -$17.1M loss to +$54.4M; guidance raised by $30-50M midpoint vs prior Q1 guidance.

revenuenet incomeAdjusted EBITDAmedical margindebt

Risk Factors

  • At-risk membership declining 10% YoY; continued rationalization may limit top-line growth.
  • Preferred stock dividends of $9.6M per quarter create a fixed charge; net income attributable to common was negative (-$0.63/share) after those dividends.
  • Cash from operations was negative $89.4M YTD; the company relies on financing (debt and equity) for liquidity.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Health Services
Analyst Consensus
75% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001832511-26-000032
Document: piii-20260810.htm0001832511-26-000032
Document: 0001832511-26-000032-index-headers.html0001832511-26-000032
Document: 0001832511-26-000032-index.html0001832511-26-000032
Document: 0001832511-26-000032.txt0001832511-26-000032
8-K Data (Synthetic)0001832511-26-000032
3 reports for PIII
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PIII — sortable, filterable
TypeNow
Oct 14, 2026
12d ago
S-3
BEARISH ★ 6/10
$4.14 $4.36▼ −5.31%▼ −6.33%$3.71 (+10.39%)
Aug 10, 2026
11w ago
8-K
BULLISH ★ 7/10
$12.37 $10.77▼ −12.93%▼ −12.53%$3.71 (−70.01%)
Jul 6, 2026
16w ago
8-K
BEARISH ★ 6/10
$10.53 $10.43▲ +0.95%▲ +1.50%$3.71 (+64.77%)
Showing 3 of 3

US Market Status

Market Open — Closes in 2h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 10, 2026